AIDS Research and Treatment
Volume 2017 (2017), Article ID 4697473, 7 pages
https://doi.org/10.1155/2017/4697473

Research Article

HIV Case Management Support Service Is Associated with Improved CD4 Counts of Patients Receiving Care at the Antiretroviral Clinic of Pantang Hospital, Ghana

Bismark Sarfo,¹ Naa Ashiley Vanderpuye,² Abigail Addison,¹ and Peter Nyasulu³

¹Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Legon, Ghana
²West Africa AIDS Foundation (WAAF), Haatso, Accra, Ghana
³Division of Epidemiology & Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Correspondence should be addressed to Bismark Sarfo; bsarfo@ug.edu.gh

Received 24 May 2017; Accepted 17 August 2017; Published 20 September 2017

Academic Editor: Patrice K. Nicholas

Copyright © 2017 Bismark Sarfo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Factors associated with individual patient-level management of HIV have received minimal attention in sub-Saharan Africa. This study determined the association between support services and cluster of differentiation 4 (CD4) counts among HIV patients attending ART clinic in Ghana. Methodology. This was a cross-sectional study involving adults with HIV recruited between 1 August 2014 and 31 January 2015. Data on support services were obtained through a closed-ended personal interview while the CD4 counts data were collected from their medical records. Data were entered into EpiData and analyzed using Stata software. Results. Of the 201 patients who participated in the study, 67% (129/191) received case management support service. Counseling about how to prevent the spread of HIV (crude odds ratio (cOR) (95% confidence interval (CI)) (2.79 (1.17–6.68)), mental health services (0.2 (0.04–1.00)), and case management support service (2.80 (1.34–5.82))) was associated with improved CD4 counts of 350 cells/mm³ or more. After adjusting for counseling about how to prevent the spread of HIV and mental health services, case management support service was significantly associated with CD4 counts of 350 cells/mm³ or more (aOR = 2.36 (CI = 1.01–5.49)). Conclusion. Case management support service for HIV patients receiving ART improves their CD4 counts above 350 cells/mm³. Incorporating HIV case management services in ART regimen should be a priority in sub-Saharan Africa.

1. Introduction

Although sub-Saharan Africa remains the home to most of new HIV infections [1], there is limited attention observed in terms of care and support provided to persons with HIV/AIDS over and above antiretroviral treatment (ART) programs. Case management support service is a special kind of service model that is usually provided to HIV patients and it consists of the provision of support services to clients and establishing a special relationship and communication between HIV service providers and their clients [2, 3]. This ensures efficient coordination in the provision of medical care and social support services to patients. Ultimately, the goal of case management support services is to effectively engage and retain patients and ensure good adherence to medication and treatment as a whole [4, 5].

In Ghana there is an increase in the number of individuals accessing HIV treatment with over 120,000 people living with HIV/AIDS currently accessing ART [6]. Expanding access to ART calls for reinforcement of effective and efficient care and support services for individuals on treatment. This is crucial for patients’ retention and treatment outcomes.

Adequate support services lead to efficient continuum of care from HIV diagnosis through to successful treatment which is central to the monitoring of HIV treatment outcomes. It has been reported that providing support services such as social, physical, and spiritual care is an important part of HIV/AIDS clinical management [7–9].

HIV-infected individuals have increased suffering such as fatigue, fever, pain, and headache [10, 11] and mental health issues [12, 13] whether patients are on ART or not. Successful treatment with positive treatment outcomes requires combination of interventions and antiretroviral therapy together with effective care and support systems. As such there is the need to design strategies and systems to address and manage specific clinical symptoms of HIV-infected individual as a way of maximizing HIV treatment and improve quality of life. The structure of case management support service could differ from one place to another. The support services that are provided at the Pantang ART clinic in Ghana to patients include how to get various laboratory tests performed, keeping up appointments, family issues including children and spousal, and food and transportation.

Studies that examined structural issues such as healthcare system factors and individual level factors relating to the continuum of HIV care, ART use, and engagement and retention in care are limited in sub-Saharan Africa [14].

Loss to follow-up (LTFU) of patients within the HIV/AIDS care continuum has not been well studied in low- and middle-income countries [15] and Ghana is even yet to identify the factors associated with LTFU in HIV-infected populations.

In Ghana, healthcare facilities that provide HIV/AIDS services do not facilitate provision of comprehensive support services such as HIV/AIDS case management, peer group support, medication adherence, and nutritional enhancement among others due to inadequate resources. Meanwhile other studies have demonstrated that the provision of support services such as health insurance and transportation services is associated with retention of care of HIV patients [16].

This study aimed at characterizing relevant care and support services that HIV-infected individuals receive at the Pantang ART clinic, and examine the association between these services and CD4 T cell counts.

2. Materials and Methods

2.1. Study Site

The study was conducted in the Pantang submunicipality, at Pantang Hospital ART Center, located at the La-Nkwantanang Madina Municipality of the Greater Accra region of Ghana. The Pantang hospital has two major health departments: the general hospital care services department and specialized psychiatry care hospital department. The ART center is attached to the general hospital care services. The Pantang ART center started in 2006 as an HIV testing and counseling unit of the Pantang General Hospital. In 2008, the unit was designated as an ART center to start offering full ART services. Currently the center renders HIV testing and counseling, provision of antiretrovirals (ARVs), Prevention of Mother-to-Child Transmission (PMTCT) services, and community health education on HIV/AIDS services.

There are over 800 HIV/AIDS patients including 20 children receiving ART services at the center presently.

2.2. Study Design

Cross-sectional study design was used for this study. Data was collected from patients on ART between August 2014 and January 2015 through medical record abstraction and personal interviews using a closed-ended questionnaire adapted from the Centers for Disease Control and Prevention (CDC), Medical Monitoring Project (MMP) questionnaire. HIV positive patients, 18 years or older, receiving care at the center with the ability to provide informed consent for interview were recruited into the study. Pregnant women were excluded. The study received ethical approval from the Ghana Health Service Ethical Review Committee (GHS-ERC: 17/05/14) and the Noguchi Memorial Institute for Medical Research Ethical Review Committee (NMIMR-IRB CPN-079/13-14) of the University of Ghana. Participants’ consent was obtained to publish the findings from this study.

2.3. Data Collection Tools

An amended version of the Centers for Disease Control and Prevention (CDC), Medical Monitoring Project (MMP) interview module, which contains questions on sociodemographic characteristics, access to healthcare, support services received by HIV patients, use of antiretroviral drugs, adherence to medication, stigma, CD4 count status and viral load, and a designed data abstraction form were the instruments used for the data collection.

2.4. Sampling Procedure and Data Collection

The sample size for this pilot study was estimated using Epi Info 7™. With a population of 800 people living with HIV (PLWH), an estimated ART coverage of 65% at the ART center and at a confidence limit of 5%, 200 participants were estimated for this study.

The participants were selected using the consecutive sampling method. Patients who fell within the eligibility criteria and visited the facility during the study period (August 2014 to January 2015) for their routine care were approached for consent to participate in the study. All who accepted to participate were interviewed. The structured interview questionnaire was used for the collection of personal information and care received by the participants. Data on sociodemographic characteristics, support services received by patients, self-reported adherence to medication, and stigma were collected. Subsequently, patients’ medical records were reviewed to validate some of the interviewed responses and also collect data on types of ART medication being used by participants as well as their CD4 counts. CD4 T cell counts were categorized into 350 cells/mm³ or below based on the World Health Organization (WHO) guideline (2010 revised in 2013) which recommended the initiation of ART when CD4 T cell counts are less than 350 cells/mm³ (WHO 2013). We could not obtain viral load status of participants due to lack of data.

2.5. Outcome of Interest

The outcome of interest is CD4 T cell counts of 350 cells/mm³ or more after participants enrollment on ART for at least six months. This is based on the World Health Organization (WHO) guideline (2010 revised in 2013) which recommended the initiation of ART when CD4 T cell counts are less than 350 cells/mm³ [17].

2.6. Exposure Variables

Participants were asked if they received the following support services: case management support service, help remembering to take HIV medicines on time, counseling about how to prevent the spread of HIV, HIV peer group support, mental health service support, drug or alcohol counseling, nutritional service support, and domestic violence support service. Each of these variables was dummy-coded with value 1 indicating they have received the service and a 0 indicating that no such service was received.

2.7. Statistical Analysis

Data were entered into EpiData version 3.1. Double entry was done to check for consistency. Entries from the EpiData were then exported into Stata version 13 (Texas, USA) for data cleaning. During the cleaning, all “Don’t know” and “Refuse to answer” responses, and a case in which there were no responses, were all treated as missing. Summary statistics were run to determine the mean age and their corresponding standard deviations as well as the generation of frequency tables for the various variables. Chi square test was performed to determine the associations between the various antiretroviral drugs and CD4 cells counts below and above 350 cells/mm³. Univariate and multivariable adjusted logistic regression models were performed to distinguish between support services and CD4 counts. value less than 0.05 was considered statistically significant. Variables which had at the univariate analysis were included in the multivariable adjusted model.

3. Results

Two hundred and one () HIV patients participated in the study. The mean age for males and females was 44.8 (SD ± 10.25) and 38.3 (SD ± 9.78) years, respectively (Table 1). Most of the participants were between 31 and 45 years (111/197; 56.3%) and over 51.7% (90/174) of them were married. There were more female participants (152/201; 75.6%) than males (49/201; 24.4%) in the study group (Table 2). Most of the participants had attained junior high school education (89/200; 44.5%). Greater proportion of the participants (121/193; 62.7%) were self-employed (Table 2). For support services that participants had received 12 months prior to the study, the majority (67.5% (129/191)) had received some form of case management for their treatment and counseling (80.6% (154/191)) about how to prevent the spread of HIV. Only 32.1% (62/193) have received nutritional services and 4.1% (8/194) had received mental health services (Table 3).

Table 1: Participants age distribution by sex.

Sex
Mean
Std dev

Male
44.79
10.25

Female
38.34
9.78

Table 2: Sociodemographic characteristics of participants.

Variable
Frequency ()
Percentage

Age (years) ()

18–30
34
17.3

31–45
111
56.4

46–65
50
25.4

>65
2
1.0

Sex ()

Male
49
24.4

Female
152
75.6

Education ()

Never attended school
25
12.5

Primary school
39
19.5

Junior high school
89
44.5

Senior high school
35
17.5

Tertiary
12
6.0

Marital status ()

Single
38
21.8

Married
90
51.7

Divorced
15
8.6

Cohabiting
23
13.2

Widowed
8
4.6

Employment status ()

Unemployed
29
15.0

Self-employed
121
62.7

Employed for wages
43
22.3

Table 3: Characteristics of support services participants received 12 months prior to the commencement of the study.

Support
Frequency ()
Percentage

Case management of HIV/AIDS ()

No
62
32.5

Yes
129
67.5

Help remembering to take your HIV medicines on time or correctly ()

No
186
73.1

Yes
50
26.9

Counselling about how to prevent the spread of HIV ()

No
37
19.4

Yes
154
80.6

HIV peer group support

No
190
98.5

Yes
3
1.5

Mental health services ()

No
186
95.9

Yes
8
4.1

Drug or alcohol counselling or treatment ()

No
161
83.0

Yes
33
17.0

Domestic violence services ()

No
182
96.3

Yes
7
3.7

Nutritional services ()

No
131
67.9

Yes
62
32.1

Over forty-seven percent (89/186) of the respondents were taking Tenofovir, Lamivudine, and Efavirenz (TDF, 3TC, and EFV, resp.) drug combination regimen (Table 4).

Table 4: Antiretroviral drugs being taken by participants.

Medication
Frequency ()
Percentage

3TC, d4T, NVP
3
1.6

AZT
1
0.5

AZT, 3TC, EFV
26
14.0

AZT, 3TC, NVP
17
9.1

AZT, 3TC, TDF
1
0.5

AZT, TDF, NVP
1
0.5

EFV, 3TC, NVP
1
0.5

Cotrimoxazole
9
4.8

TDF
4
2.2

TDF, 3TC, EFV
89
47.9

TDF, 3TC, NVP
22
11.8

TDF, FTC, EFV
11
5.9

d4T, EFV, TDF
1
0.5

3TC = Lamivudine; d4T = Stavudine; NVP = Nevirapine; AZT = Zidovudine; EFV = Efavirenz; TDF = Tenofovir.

Before enrolling on ART treatment, 47.7% (/176) had their CD4 count above 350 cells/mm³ (Table 5) and after enrolling on ART for more than six months, 64.9% (/148) had their most recent CD4 count above 350 cells/mm³ (Table 6).

Table 5: Participants first CD4 count results before taking antiretroviral medication.

CD4 count (cell/mm³)
Frequency ()
Percentage

Below 350
92
52.3

350 and above
84
47.7

Table 6: Participants most recent CD4 count results after taking antiretroviral medication for at least 6 months.

CD4 count (cell/mm³)
Frequency ()
Percentage

Below 350
52
35.1

350 and above
96
64.9

Table 7 presents the association between support services and CD4 count. Counseling about how to prevent the spread of HIV (cOR = 2.79 (CI = 1.17–6.68)), mental health services (cOR = 0.2 (CI = 0.04–1.00)), and case management support service (cOR = 2.80 (CI = 1.34–5.82)) were associated with improved CD4 counts of 350 cells/mm³ or more. After adjusting for counseling about how to prevent the spread of HIV and mental health services, case management support service was significantly (aOR = 2.36 (CI = 1.01–5.49)) associated with CD4 counts of 350 cells/mm³ or more.

Table 7: Univariate and multivariate analysis of support services participants received (12 months prior to the study), in association with their most recent CD4 count levels.

Support
Unadjusted
value
Adjusted
value

OR (95% CI)
OR (95% CI)

Case management of HIV/AIDS

disease ()

No
1 (ref)

1 (ref)

Yes
2.80 (1.34–5.82)
0.01
2.36 (1.01–5.49)
0.05

Help remembering to take HIV medicines on time or correctly

No
1 (ref)

Yes
1.52 (0.66–3.51)
0.32
ND
NA

Counselling about how to prevent the spread of HIV

No
1 (ref)

1 (ref)

Yes
2.79 (1.17–6.68)
0.02
1.83 (0.66–5.07)
0.24

HIV peer group support

No
1 (ref)

Yes
1.07 (0.09–12.07)
0.96
ND
NA

Mental health services

No
1 (ref)

1 (ref)

Yes
0.2 (0.04–1.00)
0.05
0.28 (0.05–1.70)
0.16

Drug or alcohol counselling or treatment

No
1 (ref)

Yes
0.76 (0.31–1.85)
0.54
ND
NA

Domestic violence services

No
1 (ref)

Yes
2.24 (0.24–20.61)
0.48
ND
NA

Nutritional services

No
1 (ref)

Yes
0.79 (0.38–1.67)
0.54
ND
NA

ND = not determined; NA = not applicable.

4. Discussion

This study has demonstrated that, beyond ART regimen, supporting people living with HIV (PLWH) in managing their associated problems improves their CD4 counts level.

Services that PLWHIV receive play important role in their recovery, and in this study only 32.1% and 4.1%, respectively, have received nutritional and mental health services. Inadequate nutrition has been shown to be linked with the progression of HIV/AIDS disease. It is anticipated that nutritional counseling would be an integral component of support services that HIV/AIDS patients should receive at ART clinics, because it has been recommended that nutritional support should be part of the care provided to HIV-infected patients [18]. Eighty-two percent (82%) of health facilities in Asia-Pacific, sub-Saharan Africa, and the Americas provide nutritional support services for HIV/AIDS patients [19]. Report from other studies from sub-Saharan Africa has also shown high nutritional support services for HIV/AIDS patients [20]. Surprisingly, such services (32.1%) in this Ghana data are inadequate. Furthermore, support services for patients could be different based on the clinical stage of the HIV disease such that, during stage 3, for example, where maintenance could begin once viral load has been controlled, it requires attention such as mental health issues which could influence adherence to medication. The mental health services provided to patients in the current data are also inadequate. The majority of the participants in this Ghana study were on Tenofovir, Lamivudine, and Efavirenz combination therapy. A study conducted in Barcelona, Spain, indicated that a combination regimen boosted the CD4 count and reduces viral load of participants [21].

Combination of ART medication has been recommended for developing countries under the public health approach to antiretroviral therapy by the World Health Organization [22].

Combined ART regimens have been shown to be more effective compared with a single dose regimen [23].

Early diagnosis and initiation of ART based on current treatment guidelines could reduce HIV- related morbidity and mortality [16]. The majority of the participants had first CD4 count test results below 350 cells/mm³ before their enrollment on ART. But after at least six months of ART, the CD4 count of most participants improved to above 350 cells/mm³, indicating a positive response to treatment. In a study conducted in Rome, it was discovered that initiation of ART at CD4 counts of 350–500 cells/mm³ significantly improved the CD4 count of patients and reduced mortality [24].

This study has further shown that there were associations between some of the support services including counseling, mental health, and case management services and improved CD4 counts in patients receiving ART. This association remains strong for supporting patients in managing their associated problems, after controlling for counseling and mental health services. The likelihood of having improved CD4 counts of 350 cells/mm³ or more is higher in those who received case management support services in taking care of their HIV conditions compared with those who did not.

During the roll-out of antiretroviral therapy in resource limited countries, emphasis was placed more on capacity building and sustainability of programs such as voluntary counseling and testing, with only minimal attention being paid to patient-level management issues [25]. Patient-level management issues including stigma, pain, fatigue, depression, finances, sleep difficulties, and family cannot be addressed with antiretrovirals.

Apart from case management services which are performed at the discretion of the clinic staff, and counseling patients in preventing HIV transmission, less attention has been paid to patient-level issues. This is common in many ART facilities in sub-Saharan Africa and the low patients’ level support services reported in this study are no exception.

At the Pantang ART clinic in this study, the committed staffs use a patient centered approach to delivery of ART services. Clinic staff would inquire from patients personal issues they have whenever they come in for their medications and medical check-ups. Those who have been identified to have issues other than clinical issues are triaged for support within the remit of the staff. Support services include how to get various laboratory tests performed, keeping up appointments, family issues including children and spousal, food, and transportation. These are important support services that improve upon the coping mechanisms of the patients.

These services help in strengthening the health system which impact patients’ health. A study conducted in Georgia, USA, demonstrated loss to follow-up of PLWH due to inadequate support services [25] and has recommended that healthcare systems should respond to HIV/AIDS cases with additional supportive services including appointment reminders for patients, case managers, peer-educators, and counselors among others [26]. This Pantang study has shown that, beyond ART regimen, supporting patients in managing their problems improves their CD4 counts level. Possibly, case management support strengthens compliance by patients which in effect makes the antiretrovirals work better. Admittedly, cost could be a factor in incorporating case management into the general ART regime in developing countries. It is therefore important for future studies to determine the cost component of case management in HIV/AIDS intervention in sub-Saharan Africa.

4.1. Study Limitation

The most recent CD4 count of some of the participants in this study was recorded in 2013 as they indicated that they could not afford the cost of CD4 test in private laboratories and hospitals. Therefore, the interpretation of the CD4 count must be done with caution. Also the nonavailability of viral load testing is another limitation of the study. Furthermore, since this is a cross-sectional study with consecutive sampling, the outcome cannot be generalized to the entire HIV/AIDS population on ART in Ghana. Nonetheless this study highlights important aspects of HIV/AIDS management in developing countries.

5. Conclusion

Patients on ART who received case management support service have improved CD4 count of 350 cells/mm³ or more. Incorporating HIV/AIDS case management services in ART regimen should be a priority in sub-Saharan Africa.

Additional Points

Availability of Data and Material. The datasets for the current study are available from the corresponding author on reasonable request.

Ethical Approval

Ethical approvals were obtained from the Ghana Health Service Ethical Review Committee (GHS-ERC: 17/05/14) and the Noguchi Memorial Institute for Medical Research Ethical Review Committee (NMIMR-IRB CPN-079/13-14) of the University of Ghana.

Consent

Participants’ consent was obtained to publish this study.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Bismark Sarfo conceived the research idea, designed the study, and analyzed the data. Naa Ashiley Vanderpuye, Abigail Addison, and Peter Nyasulu contributed to the study design. Bismark Sarfo, Naa Ashiley Vanderpuye, Abigail Addison, and Peter Nyasulu drafted and revised the manuscript critically for important intellectual content and gave final approval.

Acknowledgments

The authors thank Ms. Grace Tetteh, Godwin Nunoo Mensah, and all the supporting staff of the ART Clinic of Pantang Hospital. Their utmost appreciation also goes to all the study participants who willingly took part in the study. This study received funding (URF/7/SF-010/2013-2014) from the Office of Research, Innovation and Development (ORID) of the University of Ghana.

References

UNAIDS, “New HIV infections by mode of transmission in West Africa: a multicountry analysis,” Geneva: Joint United Nations Programme on HIV/AIDS2010, 2015, http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/countryreport/2010/201003_MOT_West_Africa_en.pdf.

C. J. Hajewski and M. R. Shirey, “Care coordination: a model for the acute care hospital setting,” Journal of Nursing Administration, vol. 44, no. 11, pp. 577–585, 2014.

E. H. Wagner, N. Sandhu, K. Coleman, K. E. Phillips, and J. R. Sugarman, “Improving care coordination in primary care,” Medical Care, vol. 52, pp. S33–S38, 2014.

S. E. Lehrman, D. Gentry, B. B. Yurchak, and J. Freedman, “Outcomes of HIV/AIDS case management in New York,” AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 13, no. 4, pp. 481–492, 2001.

J. Kates, Medicaid and HIV: A National Analysis, Kaiser Family Foundation, California, Calif, USA, 2011, http://kaiserfamilyfoundation.files.wordpress.com/2013/01/8218.pdf.

Ghana National AIDS Commission Program: Status of the National HIV and AIDS Response Report, 2015, http://www.unaids.org/sites/default/files/country/documents/GHA_narrative_report_2015.pdf.

D. Clark, M. Wright, J. Hunt, and T. Lynch, “Hospice and palliative care development in Africa: a multi-method review of services and experiences,” Journal of Pain and Symptom Management, vol. 33, no. 6, pp. 698–710, 2007.

M. Gysels, C. Pell, L. Straus, and R. Pool, “End of life care in sub-Saharan Africa: a systematic review of the qualitative literature,” BMC Palliative Care, vol. 10, article no. 6, 2011.

J. Stjernsward and D. Clark, “Palliative care—a global perspective,” in Oxford Textbook of Palliative Medicine, D. Doyle, G. Hanks, N. I. Cherny, and K. Calman, Eds., p. 1197, Oxford University Press, Oxford, UK, 3rd edition, 2003.

I. Corless, J. Voss, P. Nicholas et al., “Fatigue in HIV/AIDS patients with comorbidities,” Applied Nursing Research, vol. 21, no. 3, pp. 116–122, 2008.

B. E. Aouizerat, C. A. Miaskowski, C. Gay et al., “Risk factors and symptoms associated with pain in HIV-infected adults,” Journal of the Association of Nurses in AIDS Care, vol. 21, no. 2, pp. 125–133, 2010.

P. Bravo, A. Edwards, S. Rollnick, and G. Elwyn, “Tough decisions faced by people living with HIV: a literature review of psychosocial problems,” AIDS Reviews, vol. 12, no. 2, pp. 76–88, 2010.

M. Fortin, C. Hudon, E. A. Bayliss, H. Soubhi, and L. Lapointe, “Caring for body and soul: the importance of recognizing and managing psychological distress in persons with multimorbidity,” International Journal of Psychiatry in Medicine, vol. 37, no. 1, pp. 1–9, 2007.

I. Hodgson, M. L. Plummer, S. N. Konopka et al., “A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women,” PLoS ONE, vol. 9, no. 11, Article ID e111421, 2014.

M. M. Philbin, A. E. Tanner, A. DuVal et al., “Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States,” AIDS and behavior, vol. 18, no. 8, pp. 1501–1510, 2014.

D. Karus, V. H. Raveis, K. Marconi et al., “Service needs of patients with advanced HIV disease: a comparison of client and staff reports at three palliative care projects,” AIDS Patient Care and STDs, vol. 18, no. 3, pp. 145–158, 2004.

WHO, “Consolidated ARV guidelines,” 2013, http://www.who.int/hiv/pub/guidelines/arv2013/art/statartadolescents_rationale/en/.

American Diatetic Association, “Position of the American diabetic association nutrition intervention in the treatment of HIV,” Journal of the American Dietetic Association, vol. 92, pp. 477-478, 1989.

S. N. Duda, A. M. Farr, M. L. Lindegren et al., “Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration,” Journal of the International AIDS Society, vol. 17, no. 1, 2014.

A. Anema, W. Zhang, Y. Wu et al., “Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries,” Public Health Nutrition, vol. 15, no. 5, pp. 938–947, 2012.

B. Torres, N. I. Rallón, M. Loncá, A. Díaz, L. Alós, E. Martínez et al., “Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial,” AIDS Research and Human Retroviruses, vol. 30, no. 5, pp. 425–433, 2014.

World Health Organization, Scaling up Anti-Retroviral Therapy in Resource-Limited Settings: Guidelines for a Public Health Approach, WHO, Geneva, Switzerland, 2002.

L. E. Cain, R. Logan, J. M. Robins et al., “When to initiate combined antiretroviral therapy to reduce mortality and aids-defining illness in HIV-infected persons in developed countries,” Annals of Internal Medicine, vol. 154, no. 8, pp. 509–515, 2011.

J. Gallant, E. Hulbert, and C. Harley, “Health outcomes associated with the timing of antiretroviral therapy initiation,” The New England Journal of Medicine, vol. 360, no. 18, pp. 1815–1826, 2009.

M. C. Hosseinipour and M. Schechter, “Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resources,” Current HIV/AIDS Reports, vol. 7, no. 3, pp. 168–174, 2010.

J. Kelly, D. Rane, P. Wortley, and C. Drenzek, “The care continuum for people living with HIV in Georgia: how can we raise the bar?” The Journal of the Georgia Public Health Association, vol. 5, no. 1, 2015.